150 related articles for article (PubMed ID: 11340246)
1. Immunohematological findings in myelodysplastic syndrome.
Novaretti MC; Sopelete CR; Velloso ER; Rosa MF; Dorlhiac-Llacer PE; Chamone DA
Acta Haematol; 2001; 105(1):1-6. PubMed ID: 11340246
[TBL] [Abstract][Full Text] [Related]
2. Investigation for the presence of anti-erythropoietin antibodies in patients with myelodysplastic syndromes.
Voulgari PV; Hatzimichael EC; Tsiara S; Tzallas C; Drosos AA; Bourantas KL
Eur J Haematol; 2001 Jan; 66(1):31-6. PubMed ID: 11168505
[TBL] [Abstract][Full Text] [Related]
3. [Immunohematologic study in 112 patients with myelodysplastic syndromes: 10-year analysis].
Arriaga F; Bonanad S; Larrea L; de la Rubia J; López F; Sanz MA; Sanz G; Marty ML
Sangre (Barc); 1995 Jun; 40(3):177-80. PubMed ID: 7570268
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmune hemolytic anemia and myelodysplastic syndromes].
Martín Vega C; Vallespí T; Juliá A; Zuazu J; Torrabadella M
Sangre (Barc); 1989 Oct; 34(5):343-5. PubMed ID: 2617384
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
[TBL] [Abstract][Full Text] [Related]
6. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes.
Sokol RJ; Hewitt S; Booker DJ
J Clin Pathol; 1989 Oct; 42(10):1088-91. PubMed ID: 2584409
[TBL] [Abstract][Full Text] [Related]
8. [Allo- and autoantibody in a case of autoimmune hemolytic anemia associated with a myelodysplastic syndrome].
Iturbe T; Azaceta G; Varo M; Callén L
Sangre (Barc); 1996 Oct; 41(5):403-4. PubMed ID: 9026930
[No Abstract] [Full Text] [Related]
9. Anti-erythroblast autoimmunity in early myelodysplastic syndromes.
Barcellini W; Zaninoni A; Imperiali FG; Boschetti C; Colombi M; Iurlo A; Zanella A
Haematologica; 2007 Jan; 92(1):19-26. PubMed ID: 17229631
[TBL] [Abstract][Full Text] [Related]
10. Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome.
Cukrová V; Neuwirtová R; Dolezalová L; Belicková M; Bartůnková J; Jonásová A; Cermák J; Homolková H; Malíková I
Exp Hematol; 2009 Mar; 37(3):386-94. PubMed ID: 19136196
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome.
Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK
Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781
[TBL] [Abstract][Full Text] [Related]
12. Red Blood Cell Transfusion in Patients With Autoantibodies: Is It Effective and Safe Without Increasing Hemolysis Risk?
Park SH; Choe WH; Kwon SW
Ann Lab Med; 2015 Jul; 35(4):436-44. PubMed ID: 26131416
[TBL] [Abstract][Full Text] [Related]
13. [Myelodysplastic syndrome classification].
Ghariani I; Braham N; Hassine M; Kortas M
Ann Biol Clin (Paris); 2013; 71(2):139-44. PubMed ID: 23587576
[TBL] [Abstract][Full Text] [Related]
14. Autologous lymphocytes inhibit hemopoiesis in long-term culture in patients with myelodysplastic syndrome.
Baumann I; Scheid C; Koref MS; Swindell R; Stern P; Testa NG
Exp Hematol; 2002 Dec; 30(12):1405-11. PubMed ID: 12482502
[TBL] [Abstract][Full Text] [Related]
15. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
[TBL] [Abstract][Full Text] [Related]
16. Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.
Singhal D; Kutyna MM; Chhetri R; Wee LYA; Hague S; Nath L; Nath SV; Sinha R; Wickham N; Lewis ID; Ross DM; Bardy PG; To LB; Reynolds J; Wood EM; Roxby DJ; Hiwase DK
Haematologica; 2017 Dec; 102(12):2021-2029. PubMed ID: 28983058
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of myelodysplastic syndrome and multiple myeloma.
Tsiara S; Economou G; Panteli A; Isaakidis P; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 1999 Dec; 18(4):565-6. PubMed ID: 10746986
[TBL] [Abstract][Full Text] [Related]
18. Two cases of myelodysplastic syndrome with extramedullary polyclonal plasma cell proliferation and autoantibody production: possible role of soluble Fas antigen for production of excessive self-reactive B cells.
Katsuki K; Shinohara K; Kameda N; Yamada T; Takeda K; Kamei T
Intern Med; 1998 Nov; 37(11):973-7. PubMed ID: 9868964
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies.
Huang TC; Ko BS; Tang JL; Hsu C; Chen CY; Tsay W; Huang SY; Yao M; Chen YC; Shen MC; Wang CH; Tien HF
Leukemia; 2008 Mar; 22(3):544-50. PubMed ID: 18094713
[TBL] [Abstract][Full Text] [Related]
20. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
Omine M; Yamauchi H
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
